Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

0.6514
Delayed Data
As of Jun 28
 -0.0286 / -4.21%
Today’s Change
0.36
Today|||52-Week Range
2.67
+75.01%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$103.4M

Company Description

CytRx Corp. operates as a biopharmaceutical research and development company specializing in oncology. It provides clinical development of aldoxorubicin oncology pipeline for the treatment of cancer. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.

Contact Information

CytRx Corp.
11726 San Vicente Boulevard
Los Angeles California 90049
P:(310) 826-5648
Investor Relations:

Employees

Shareholders

Mutual fund holders6.03%
Individual stakeholders5.15%
Other institutional12.09%

Top Executives

Steven A. KriegsmanChairman, President & Chief Executive Officer
Daniel J. LevittChief Operating & Medical Officer
John Y. CalozChief Financial Officer & Treasurer
Shanta P. ChawlaSenior Vice President-Drug Development
Felix KratzVice President-Drug Discovery